A role for naphthoquinones in oxidative phosphorylation has been demonstrated with a cell-free system from Mycobacterium phlei.1-3 The natural naphthoquinone of this microorganism, vitamin K9H, functions between the flavoprotein and cytochrome b on the NAD+-linked and malate-vitamin K reductase pathways.3' 4 Evidence has been presented for the existence of a phosphorylative site between the natural quinone and cytochrome b.2, 5, 6 Restoration of the quinone function has been shown to occur on supplementation with vitamin K, (I) to the quinone-de-
A role for naphthoquinones in oxidative phosphorylation has been demonstrated with a cell-free system from Mycobacterium phlei.1-3 The natural naphthoquinone of this microorganism, vitamin K9H, functions between the flavoprotein and cytochrome b on the NAD+-linked and malate-vitamin K reductase pathways. 3' 4 Evidence has been presented for the existence of a phosphorylative site between the natural quinone and cytochrome b.2, 5, 6 Restoration of the quinone function has been shown to occur on supplementation with vitamin K, (I) to the quinone-de- Evidence has been obtained which suggests that certain naphthoquinones may take part directly in the phosphorylative events.5-8 Although oxidation by the quinone-depleted system can be restored by numerous naphthoquinones, the requirements for restoration of phosphorylation are more specific. For example, certain quinones such as dihydrophytyl vitamin K1 restore oxidation by the same pathway as vitamin K1, but fail to restore phosphorylation at this site. The recent finding of a dependence on inorganic phosphate for tritium incorporation into the naphthoquinone under conditions of oxidative phosphorylation further suggests a direct role for phosphate during the reductive process.7
A number of mechanisms have been proposed for the participation of quinones in oxidative phosphorylation.9'-3 Chemical and biological experiments with model compounds such as menadiol phosphate10 14 Examination of the distribution of P32-labeled material in the ether-extractable fraction revealed that only one main area contained p32 label and that this area corresponded to the new quinol derivative of vitamin K1 (Rf 0.85). A spot corresponding to dihydrovitamin K1 (Rf 0.60) was occasionally observed; however, phosphate was not associated with this material. The inability to find dihydrovitamin K1 consistently as a product was due to the rapid autoxidation which occurs with this compound.
The conditions for maximal formation of this compound were investigated. Incubation of the system for 30 min was required for accumulation of the derivative; however, further incubation failed to yield larger amounts. The phosphorylated derivative of vitamin K1 was not formed in the absence of substrate, or under aerobic conditions. In the absence of inorganic phosphate, the compound was not formed (as determined by the lack of fluorescent material at Rf 0.85); however, material corresponding to dihydrovitamin K1 (Rf 0.60) was detected. The extent of conversion of vitamin K1 to the new compound was estimated by the amount of p32 associated with the purified material and ranged between 0.3 and 0.7 per cent. Formation of the phosphorylated derivative of vitamin K1 was completely inhibited by Dicumarol (10-4 M), and partially inhibited by pentachlorophenol (10-4 M). Both KCN (10-3 M) and 2-nonylhydroxyquinoline N-oxide (15 jg), compounds which inhibit electron transport after the quinone site, failed to inhibit the formation of the quinol phosphate derivative.
The fractionated components of the system from M. phlei obtained by centrifugation at 140,000 X g were tested for their ability to form the new compound. Formation of the phosphorylated derivative of vitamin K1 was found to occur with the particulate fraction alone or in combination with the supernatant fraction, but failed to occur with the supernatant fraction alone. This is of particular interest since the site of the endogenous naphthoquinone interaction with the respiratory chain is in the particles.
Evidence that the enzymatically formed quinol phosphate was derived from vitamin K1 was obtained following incubation of C14-labeled17 vitamin K1 with the system from M. phlei. Material corresponding to the phosphate derivative was formed and detected by its fluorescence. Two areas containing C14 label were (Fig. 1B) . The C14 label was found in the same area as the P32 label in Figure 1A . The dependence on inorganic phosphate was tested with C'4-labeled vitamin Ki. In the absence of inorganic phosphate, the C14 label was only detected in the spot corresponding to vitamin K,. failed to result in the formation of the quinol phosphate of either analogue (Fig. 2) . These results further indicate the specificity of the reaction with respect to the ,3 position of the side chain and the methyl group in the 2 position of the naphthoquinone nucleus. Similar results have been obtained in studies of the specific quinone structures which are required for restoration of oxidative phosphorylation2' 5 and for tritium incorporation into vitamin K,.7
The absorption spectrum of the enzymatically formed phosphorylated derivative of vitamin K, was obtained following purification by two-dimensional paper chromatography (Fig. 3) . This material had two major absorption peaks at 230 and 248 m1u and two minor peaks at 324 and 338 mMu. This spectrum of this compound was found to lack the four peaks that are characteristic of the conjugated naphtho- quinone ring, but was similar to that exhibited by quinol derivatives. Although the absorption at 230 mp was first thought to be due to contamination with another compound, attempts to remove it by further purification have been unsuccessful. The absorption spectrum of the enzymatically formed compound differed from that exhibited by the mono-or diphosphate derivative of vitamin K1 and from that exhibited by dihydrovitamin K1. In many respects the enzymatically formed compound exhibited a spectrum that was similar, but not identical, to the 6-hydroxychromanol and the 6-chromanyl phosphate derivatives of vitamin K1, differing in the additional peak at 230 mit, which is associated with the new compound. The IR spectrum of the enzymatically formed derivative of vitamin K1 was compatible with that of a phosphorylated quinol structure. Although the enzymatically formed material was similar to the synthetic 6-chromanyl phosphate derivative of vitamin K1 in. UV, IR, and chromatographic behavior, other properties of the enzymatically formed compound were found to differ considerably from the synthetic compound. Unlike synthetic chromanyl phosphate, the enzymatically formed compound was unstable and decomposed in 4-7 days when stored in the dry state at -14°. Some stabilization was achieved by storage under nitrogen. In addition, the compound, unlike the synthetic material, was decomposed on silica gel plates. Thus, although the new phosphorylated derivative resembles the 6-chromanyl phosphate derivative of vitamin K1, it probably differs in structure. Further analysis is in progress to elaborate this point.
The enzymatic formation of a phosphorylated derivative of vitamin K, is of particular interest, since vitamin K1 is necessary for restoration of oxidative phosphorylation by the quinone-depleted system. The mechanism and site of phosphate addition are unknown; however, studies of the site of deuterium incorporation into vitamin K, suggest that it does not occur following quinone methine formation.'8 Although the role of the phosphorylated derivative of vitamin K in biological oxidation is unknown, this bacterial system may shed some light on both the mechanism of phosphate addition and utilization at the quinone site in the respiratory chain.
Summary.-A phosphorylated derivative of vitamin K1 was formed enzymatically by extracts of Mycobacterium phlei. Formation of the new derivative was dependent on the presence of an electron donor, inorganic phosphate, extract, and vitamin K1 or the natural naphthoquinone (vitamin K9H). The ultraviolet absorption spectrum of the derivative was similar to that of synthetic chromanol derivatives of vitamin K1 and provided evidence that the enzymatically formed compound is a quinol. Although the enzymatically formed quinol phosphate comigrated with the synthetic chromanyl phosphate derivative of vitamin K1, the two compounds exhibited marked differences in stability. Phosphorylated derivatives
were not formed with vitamin K1 in which the 3-y position of the side chain was saturated or in which the methyl group (2 position) was lacking.
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